These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17234210)

  • 1. The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.
    Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
    J Mol Biol; 2007 Mar; 367(1):224-33. PubMed ID: 17234210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
    Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of complement component C2A: implications for convertase formation and substrate binding.
    Milder FJ; Raaijmakers HC; Vandeputte MD; Schouten A; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P
    Structure; 2006 Oct; 14(10):1587-97. PubMed ID: 17027507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of high affinity C5 convertase of the classical pathway of complement.
    Rawal N; Pangburn MK
    J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
    Ponnuraj K; Xu Y; Macon K; Moore D; Volanakis JE; Narayana SV
    Mol Cell; 2004 Apr; 14(1):17-28. PubMed ID: 15068800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.
    Kuttner-Kondo LA; Dybvig MP; Mitchell LM; Muqim N; Atkinson JP; Medof ME; Hourcade DE
    J Biol Chem; 2003 Dec; 278(52):52386-91. PubMed ID: 14561755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
    J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
    Rawal N; Rajagopalan R; Salvi VP
    J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
    J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM; Colomb MG
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human complement system: assembly of the classical pathway C3 convertase.
    Kerr MA
    Biochem J; 1980 Jul; 189(1):173-81. PubMed ID: 6906228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
    Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
    J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of complement C5 convertase enzymes.
    Pangburn MK; Rawal N
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1006-10. PubMed ID: 12440962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.
    Mortensen S; Jensen JK; Andersen GR
    J Biol Chem; 2016 Aug; 291(32):16494-507. PubMed ID: 27252379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
    Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
    EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.
    Laursen NS; Andersen KR; Braren I; Spillner E; Sottrup-Jensen L; Andersen GR
    EMBO J; 2011 Feb; 30(3):606-16. PubMed ID: 21217642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural biology of the alternative pathway convertase.
    Xu Y; Narayana SV; Volanakis JE
    Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.